mRNA Lipid Nanoparticles Show Promise for Non-Surgical Cataract Treatment in Rat Studies
核心洞察
Researchers developed lipid nanoparticles (搜索) containing mRNA (搜索) encoding lanosterol synthase (搜索) that successfully reversed cataract (搜索) formation in two rat models when delivered via intracameral injection.
The treatment elevated lanosterol synthase (搜索) protein levels and lanosterol concentrations in rat lenses, leading to improved lens transparency and reduced protein aggregation without significant toxicity.
This novel mRNA (搜索)-based approach could potentially offer a pharmacological alternative to cataract (搜索) surgery, addressing a critical unmet need for the 95 million people worldwide affected by cataracts.
Researchers have developed a novel mRNA (搜索)-based therapy delivered via specialized lipid nanoparticles (搜索) that successfully reversed cataract (搜索) formation in rat models, potentially offering the first pharmacological treatment for a condition that currently requires surgical intervention. The study, published in Nature Communications, demonstrates significant therapeutic potential for addressing cataracts, which affect over 95 million people globally and represent the leading cause of vision impairment (搜索) and blindness (搜索) worldwide.
Novel Lipid Nanoparticle Platform Enables Ocular mRNA Delivery
The research team developed pB-UC18 lipid nanoparticles (搜索) (LNPs) specifically optimized for ocular mRNA (搜索) delivery. These nanoparticles, measuring 173 ± 6 nm in diameter with a polydispersity index of 0.17 ± 0.02, successfully encapsulated mRNA encoding human lanosterol synthase (搜索) (hLSS), a critical enzyme that catalyzes the production of lanosterol and helps maintain lens transparency by preventing crystallin (搜索) protein aggregation.
The optimized formulation demonstrated superior performance compared to clinically approved SM-102 LNPs in ocular delivery efficiency. Intracameral injection emerged as the most effective delivery route, with bioluminescence signals peaking at 26 hours and sustaining elevated levels at 48 hours, predominantly arising from the lens tissue.
Therapeutic Efficacy Demonstrated in Two Cataract Models
The researchers evaluated their mRNA (搜索) therapy in two distinct rat cataract (搜索) models: selenium-induced nuclear cataracts and galactose-induced cortical cataracts. In the selenium-induced model, slit-lamp examination revealed remarkable improvement in lens turbidity in treated eyes compared to untreated contralateral eyes. Cataract development in injected eyes was significantly lower than in uninjected eyes, with histological analysis showing regular lens fiber cell arrangements and minimal vacuoles compared to considerable structural disruption in untreated cataracts.
In the galactose-induced cataract (搜索) model, treatment with mRNA (搜索)-loaded LNPs resulted in progressive reduction of relative turbidity areas, including annular equatorial-like vesicles and radial turbidity in lens cortex. Pathological analysis confirmed obvious remission of lens fiber swelling, while TUNEL staining revealed dramatically decreased apoptotic cell death in lens epithelium and cortex.
Molecular Mechanisms and Safety Profile
Immunofluorescence analysis confirmed elevated lanosterol synthase (搜索) levels in treated lenses, with highly expressed proteins predominantly localizing in the eyeball wall, lens epithelium, and lens cortex. Liquid chromatography-mass spectrometry quantitative analysis demonstrated that intracameral injection of mRNA (搜索)-loaded LNPs significantly increased lanosterol levels in lenses of Wistar rats across different age groups.
Comprehensive safety assessments revealed no significant ocular lesions, histological alterations in eyes or major organs, or changes in routine blood parameters, hepatic, and renal function. The treatment showed biocompatibility at physiological pH while demonstrating pH-sensitive membrane disruption within the endosomal pH range, suggesting effective endosomal escape potential.
Clinical Implications and Future Directions
Currently, no drugs are available for cataract (搜索) treatment, with surgical intervention being the only method for restoring vision. However, globally fewer than one-fifth of patients with cataract-induced vision impairment (搜索) have received surgical intervention due to contraindications, cost, accessibility limitations, and insufficient expertise in developing regions.
The successful demonstration of mRNA (搜索)-mediated lanosterol synthase (搜索) expression represents a significant advancement toward developing affordable pharmacological treatments for cataract (搜索) reversal. The approach leverages the emerging field of mRNA therapeutics, which allows direct cytoplasmic translation of exogenous mRNA while avoiding the risk of insertional mutagenesis caused by transgene integration.
Technical Innovation in Ocular Drug Delivery
The study's technical achievements include the development of an aromatic scaffold-based ionizable lipid component that enables efficient mRNA (搜索) encapsulation through electrostatic interactions. The researchers demonstrated that cellular uptake occurs via multiple pathways, including clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis, as evidenced by inhibitor studies using chlorpromazine, methyl-β-cyclodextrin, and 5-(N-ethyl-N-isopropyl)-amiloride.
The mature lens, despite being an avascular tissue, possesses a unique microcirculatory system that facilitates transport of mRNA (搜索) formulations from the anterior chamber to the lens, enabling the observed therapeutic effects. This finding has important implications for future ocular drug delivery strategies targeting lens-related disorders.